SEC Form 4 · accession 0001140361-15-001932
Adverum Biotechnologies, Inc. · ADVM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven Daniel Schwartz
Director
Period of report
Jan 13, 2015
Accepted (ET)
Jan 15, 2015 · 4:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001501756
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 13, 2015 | S | 91,000 | $55.46 | D | 468,306 | D |
Table II — derivative securities
No Table II lines on this filing.